760: Cellular Genomics - Molecular Cytogenetic Investigation of Canine Soft Tissue Sarcomas

Grant Status: Closed

Grant Amount: $135,963
Dr. Matthew Breen, PhD, North Carolina State University
October 1, 2007 - September 30, 2009
Sponsor(s): Akita Club of America, Inc., American Bloodhound Club, American Boxer Charitable Foundation, American Bullmastiff Association, American German Shepherd Dog Charitable Foundation, Inc., Atlantic States Briard Club, Inc., Bernese Mountain Dog Club of America, Briard Club of America Health & Education Trust, Chinese Shar-Pei Charitable Trust, Collie Health Foundation, Doberman Pinscher Club of America, Flat-Coated Retriever Foundation, French Bulldog Club of America, German Shepherd Dog Club of America, Golden Retriever Foundation, Labrador Retriever Club, Orthopedic Foundation for Animals, Portuguese Water Dog Club of America, Inc., Rhodesian Ridgeback Club of the United States, Rottweiler Health Foundation, San Joaquin Kennel Club, Scottish Terrier Club of America, St. Bernard Club of America, Starlight Fund, Vizsla Club of America Welfare Foundation
Breed(s): Australian Shepherd, Bernese Mountain Dog, German Shepherd Dog, Flat-Coated Retriever, Golden Retriever
Research Program Area: Prevention

Project Summary

Histiocytic malignancies, often referred to as histiocytic sarcoma (HS) and/or malignant histiocytosis (MH) are of major health concern to a variety of breeds, including Bernese Mountain Dog and Flat coated Retriever. In this project we aimed to recruit and analyze 75 cases of MH/HS from these two breeds, using genome-wide array based comparative genomic hybridization (aCGH), multicolour fluorescence in situ hybridization (FISH) analysis and loss of heterozygosity (LOH) analysis. Importantly, this study included BMDs from both the USA and from France. As such we were able to determine that there are no significant differences the genome wide aberrations profiles of either population, suggesting that the Berner populations of the USA and Europe may be considered as a single large population for the purpose of genetic investigations. Due to additional resources becoming available, we were able to evaluate a total of 133 cases of MH/HS from BMDs and FCRs, and identify numerous recurrent DNA copy number that are shared between these breeds and unique to each breed, The regions of the genome recurrently involved have been interrogated and contain several key genes that are known to be associated with the cancer process. The data in this study revealed several key findings: 1) MH/HS from BMDs resident in the USA and in France have recurrent DNA copy number changes that do not differ significantly, suggesting that the strong association between breed and disease type is not affected by the gene pool of the breed. This indicates that we may be able to consider the BMDs in USA and Europe as a single population. Importantly, as we develop new treatments for this devastating cancer, they likely will apply to all BMDs with MH/HS, regardless of geographic origin. 2) Analysis of histiocytic malignancies from BMDs and FCRs indicates that, in general, there is a gross level of shared genetic changes, with 23 regions across both breeds being recurrent in >30% of the cases. The five most frequently occurring shared regions were highly recurrent in each breed (present in >50% of the cases) and so these data suggest that there is a strong association between genomic change and histiocytic malignancies. 3) At least three of these five highly recurrent shared regions contain genes that are known to be associated with cancers. 4) This study detected 13 aberrant region of the canine genome (on seven different chromosomes) that are significantly associated with the presence of HS affecting either internal organs or just a limb. This association also separated breed (BMD 'vs' FCR) and so it is not possible to determine if there is a correlation between 1) breed and cytogenetic profile, or between 2) anatomical location of the MH tumors internal masses and cytogenetic profiles, since there is such a strong association between BMDs and the presence of internal masses. To resolve this we would need to investigate the cytogenetic profiles of other breeds that present with internal MH masses. Further analysis would allow us to determine if it mass location or breed that drives the cytogenetic profiles. 5) Analysis of 25 cases of hemangiosarcoma in a range of breeds, using 1Mb resolution aCGH analysis, revealed the presence of highly chaotic genome reorganization. Many of the chromosome changes present are shared with other cancers, but we are unable to form any concrete conclusions about breed association or disease association without further case analysis. The next phase of this investigation will be to evaluate the status of the genes we have identified to be in regions of significance, both in affected and unaffected individuals.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Make an Investment Today:

  • $40
  • $60
  • $100
  • $250
  • Give Now
Connect With Us:
Get Canine Health News:
Please leave this field empty

© 2015 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software